Connect with us

Technology

Selvita reports Q1 2026 results and launches strategic options review

Published

2 weeks ago

on

KRAKÓW, Poland, May 21, 2026 /PRNewswire/ — Selvita S.A. (WSE: SLV), one of the leading Drug Discovery and Development organizations in Europe, has published its financial results for Q1 2026 and latest backlog. The Company has decided to launch a strategic options review for the Group’s further development and to maximize long-term shareholder value.

The Group’s operating revenues in Q1 amounted to EUR 19.1 million, at the upper end of the preliminary estimated results range of EUR 18.4-19.3 million. The EBITDA margin(1) reached 14%, compared to the estimated range of 13-16%. As a result of the cost-saving program implemented in H2 2025, operating costs in Q1 2026 were reduced by approximately EUR 1.5 million.Drug Development segment: Commercial revenues increased by 6% y/y in Q1 2026 to EUR 6.2 million, representing 35% of the Group’s commercial revenues. Segment EBITDA amounted to EUR 1.7 million, up 2% y/y(1). Segment backlog increased 15% y/y supporting the Group’s expectation of continued future growth driven by strategic alignment to fast-growing modalities.Drug Discovery segment: Commercial revenues in Q1 2026 amounted to EUR 11.6 million, compared to EUR 15.6 million in the prior year. Segment EBITDA(1) amounted to EUR 1.0 million, compared to EUR 1.9 million in Q1 2025.  This was primarily due to the continuing challenging market for outsourced European drug discovery services companies and some project delays.The full-year 2026 backlog as of May 18, 2026 stands at EUR 58.1 million(2) compared to EUR 58.9 million last year.A webcast to discuss Selvita’s Q1 results and outlook for 2026 will be held on May 21 at 11:00 CET. The event will be available at live.selvita.comSelvita announced the launch of a strategic review to assess options to support the Group’s further development and maximize shareholder value.

Boguslaw Sieczkowski, Co-Founder, significant shareholder and Chief Executive Officer of Selvita said:

“We are observing a progressive recovery in the biotechnology sector, particularly in the United States. However, the market remains volatile, as reflected, amongst other factors, in our Q1 results. We are focusing our efforts on ensuring that the subsequent periods show clear improvement, reflecting the acceleration of growth in Drug Development and a stabilized performance in Drug Discovery. Our profitability is supported by the cost-saving program implemented in the second half of 2025.

“The Drug Development segment has grown by 20-25% in recent years and is now a key growth driver for the Group, already accounting for more than one-third of commercial revenues. We see potential for its further development and have identified specific pathways by which we can accelerate growth in this segment.

“The Drug Discovery segment continues its transformation, driven by ongoing structural changes in the outsourced European drug discovery services market. Last year, we optimized the segment’s resources. We are currently focusing our efforts on more complex, high-margin services and increasing automation.”

Dariusz Kurdas, Management Board Member and Chief Financial Officer of Selvita, said:

“With EUR 19.1 million in operating revenues and a 14% EBITDA margin, we came in the middle of the range of the Q1 preliminary estimates published earlier. In the Drug Discovery segment we observed some project delays. These projects are still expected in the remaining quarters of the year, supporting improved financial performance compared to Q1. This year, we expect an improvement in profitability thanks to the approximately EUR 6.4 million in savings under the optimization program.”

STRATEGIC OPTIONS REVIEW

Selvita has continued to observe contrasting market dynamics across Drug Discovery and Drug Development.

In Drug Discovery, the European outsourced services market has remained challenging. However, the Group sees encouraging signs in the biotechnology funding environment and preliminary signs of increased levels of new pipeline opportunities which will support improved performance for the remainder of 2026 compared to Q1. Over the medium term, the Group expects continued headwinds in certain areas of small molecule Drug Discovery, whilst demand for high value-add and integrated services, especially for advanced modalities, is expected to continue to grow.

In Drug Development, the Group expects to see continued momentum in demand for services, notably in fast-growing advanced modalities.

In light of this market backdrop, Selvita has commenced a broad strategic review to assess options which would support the Group in achieving larger scale and maximizing long-term shareholder value.

The Group is considering, and is open to, a variety of strategic options, which may include a take private transaction, or an acceleration of Selvita’s M&A and organic growth initiative capital deployment strategy. This includes scenarios where additional financing would be considered solely to support such value-accretive opportunities and incremental growth initiatives.

Selvita has not set a timetable for the review, nor has it made any decisions at this stage regarding the selection of or preference for any option. Updates on the conclusion of the strategic review will be publicly communicated by Selvita as and when appropriate, and in accordance with applicable regulations.

The strategic options review will be conducted with a strong focus on uninterrupted client service, operational stability, and continued excellence in project delivery.

To facilitate the strategic review, Selvita has engaged Rothschild & Co as financial adviser.

Boguslaw Sieczkowski said:

“It is our belief that the Drug Discovery and Drug Development markets are evolving to favour players of larger scale with broad geographic and service offering capabilities across modalities. We do not believe the Group’s current valuation reflects its growth trajectory in Drug Development and unique capabilities and market positioning in Drug Discovery. We, therefore, think that now is an appropriate time to assess our potential strategic options. The underlying premise of the process is to improve the prospects of each of the Group’s segments and deliver shareholder value.”

Q1 2026 FINANCIAL RESULTS

Operating revenues in Q1 2026 amounted to EUR 19.1 million, compared to EUR 21.8 million in the prior year. The negative impact of foreign exchange differences on revenues amounted to approximately EUR 0.2 million.

Group EBITDA in Q1 2026 amounted to EUR 2.7 million, compared to EUR 3.6 million in the prior year(1). The EBITDA margin reached 14%. Savings resulting from the implemented optimization program amounted to approximately EUR 1.5 million.

Commercial revenues in the Drug Discovery segment in Q1 2026 amounted to EUR 11.6 million, compared to EUR 15.6 million in the prior year. Segment EBITDA(1) amounted to EUR 1.0 million, compared to EUR 1.9 million in the prior year.

Commercial revenues in the Drug Development segment in Q1 2026 amounted to EUR 6.2 million, up 6% y/y, already accounting for 35% of total commercial revenues. Segment EBITDA reached EUR 1.7 million, up 2% y/y, corresponding to a margin of 27%(1).

BACKLOG FOR 2026(2)

The Group’s backlog for 2026 amounts to EUR 58.1 million compared to EUR 58.9 million in the same period last year.

The backlog in the Drug Discovery segment stands at EUR 35.3 million (down 13% y/y), while in the Drug Development segment it amounts to EUR 19.4 million (up 15% y/y).

DRUG DISCOVERY TECHNOLOGIES DEVELOPMENT PROGRAM FOR 2026-2029

In recent quarters, Selvita secured four non-dilutive grants with a combined subsidy value of EUR 26.4 million. Nearly half of this amount – EUR 12.0 million – will be invested in the development of advanced services in 2026-2029. Together, these projects represent the most intensive technology development program in the Group’s history, spanning most departments within the Drug Discovery segment and incorporating a significant AI component.

The remaining portion of the grant funding will support infrastructure development, including the acquisition of state-of-the-art equipment and, in 2028-2029, the expansion of Selvita’s own laboratory space in Kraków. The potential investment in new, specialized research facilities will be financed through a combination of grant funding (approx. 40%), bank debt (approx. 50%), and the Group’s own funds (approx. 10%). In March 2026, Selvita signed a loan agreement securing financing for the investment. The largest share of capital expenditures is planned for the final phase of the investment, scheduled for 2029.

     (1) Results exclude non-cash costs of the non-dilutive employee incentive program.
     (2) Backlog as of May 18, 2026 and May 19, 2025; includes the revenues already invoiced in the financial year and portfolio of orders for the financial year.

All % calculated from PLN. All values are calculated from PLN using an average exchange rate for the respective reporting period.

About Selvita (WSE: SLV; sWIG80)

Selvita is one of the leading Drug Discovery and Development organizations in Europe. The Company provides comprehensive solutions supporting clients and their programs across a broad range of therapeutic areas, with expertise in infectious diseases, inflammation, fibrosis, and oncology. Selvita offers a wide range of standalone and fully integrated drug discovery and development solutions. Its service portfolio spans the entire value chain, from early-stage drug discovery to preclinical development, for both small molecules and therapeutic antibodies.

The Selvita Group has been operating since 2007 and employs approximately 900 highly qualified specialists. More than 30% of Selvita’s scientists hold a PhD degree. The Group’s headquarters and main laboratories are located in Kraków, Poland, with additional research facilities in Poznań, Wrocław, and Zagreb, Croatia. The Company’s sales offices are located in major global biotech hubs, including the Boston and San Francisco Bay Areas in the United States, as well as Cambridge in the United Kingdom.

Selvita is listed on the Warsaw Stock Exchange (WSE: SLV) and is a component of the sWIG80 index.

For more information, please visit: www.selvita.com

 

View original content:https://www.prnewswire.com/news-releases/selvita-reports-q1-2026-results-and-launches-strategic-options-review-302778547.html

SOURCE Selvita S.A.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Vodafone Business and Geely Technology Europe Extend Partnership to Drive Vehicle Innovation

Published

39 minutes ago

on

June 3, 2026

By

SINGAPORE and LONDON, June 3, 2026 /PRNewswire/ — Vodafone Business and Geely Technology Europe (GTEU), the European R&D organisation within Geely Auto Group, have extended their partnership to include Internet in the Car, Mobile Private Networks, and Cloud Connect solutions.

The Internet in the Car service from Vodafone Business supports capabilities such as diagnostics and over-the-air software updates, while Cloud Connect ensures secure data transfer between vehicles and cloud systems. This means Geely can monitor vehicle’s performance and support improvements to the driver experience.

In addition, Vodafone provides secure and reliable connectivity across Geely Technology Europe’s operations in Germany and Sweden, as well as with its pan-European sales teams.  

GTEU plays a key role in developing the vehicle architectures, digital platforms, and intelligent systems. These provide customers with highly responsive integrated in-car internet and digital services such as dynamic EV charging planning and 3D lane guidance. Central to this is equipping vehicles with the latest software, data, and connected services. 

Moving beyond simple transport solutions
Giovanni Lanfranchi, CEO at Geely Technology Europe, said: “We’ve moved beyond simple transport solutions. Today, vehicles can be continuously improved through software, with data and connectivity enabling a more responsive and personalised user experience over time.”

Vodafone Business’ vehicle services support GTEU in responding to customer insights, continuously enhancing its vehicles long after they leave the showroom. One example is Zeekr Navigation, where secure, always‑on connectivity enables instant in‑vehicle customer feedback. This shortens development cycles and improves GTEU’s ability to identify issues and deploy improvements rapidly.

Fanan Henriques, Vodafone Business Product and International Business Director of Vodafone Business, added: “As the adoption rate of electric vehicles continues to grow, the opportunities to enhance their safety, efficiency and the user experience through digital connectivity are significant. We’re supporting Geely’s growth in vehicle sales across Europe and its operations with a secure, multi-service digital infrastructure.” 

98% of vehicles connected
Vodafone Business is providing solutions tailored to international cybersecurity, data protection, and regulatory compliance needs, while enabling Geely to scale rapidly across regions by leveraging Vodafone’s extensive global network. For example, Vodafone Internet in the Car service combines Vodafone’s global managed IoT connectivity platform, which currently has over 240 million connections worldwide, with local internet service providers. 

By 2030, it’s expected that more than 98% of new passenger vehicles sold will be connected. Vodafone Business, working with Geely, is ready to help drive this expansion.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/vodafone-business-and-geely-technology-europe-extend-partnership-to-drive-vehicle-innovation-302789925.html

SOURCE Vodafone Business and Geely Technology Europe

Continue Reading

Technology

Beijing Review: Wisdom Without Borders: People are born with different talents, but knowledge grows only through learning

Published

39 minutes ago

on

June 3, 2026

By

BEIJING, June 3, 2026 /PRNewswire/ — “People are born with different talents, but knowledge grows only through learning.” The quote comes from Lunheng, a work written by Eastern Han Dynasty (25-220) thinker Wang Chong. It means that although people differ in terms of natural gifts, their knowledge of the world and the skills they build are all shaped through learning.

 

A society that values learning is bound to be energetic and pioneering, and reading is one of the most important paths to learning. People everywhere have valued reading since ancient times–and China is no exception. From Su Qin of the Warring States period (475-221 B.C.), who kept himself awake while studying by pricking his thigh with an awl, to Kuang Heng of the Western Han Dynasty (206 B.C.-A.D. 25) , who, unable to afford candles, famously chiseled a hole through a wall to borrow light from his neighbor’s candle to read at night, and Che Yin of the Eastern Jin Dynasty (317-420), who read by the glow of fireflies gathered in a silk bag, these well-known tales of reading have continued to inspire generations.

Since the launch of its reform and opening-up policy in 1978, China has stepped up its efforts to boost interest in reading, and build a learning society. Since the new era began in 2012, this nationwide reading drive has evolved from a broad social call into a national strategy. Since 2014, the phrase “fostering a love of reading among the public” has been included in the annual government work report for 13 consecutive years. The outline of the 15th Five-Year Plan (2026-30) also calls for further promoting reading initiatives nationwide to foster a reading culture across all segments of society.

Libraries, community reading rooms, rural bookhouses and other public reading spaces have spread across both the urban and rural landscapes. Brick-and-mortar bookstores, specialty bookshops and cultural salons have created immersive settings for more engaged reading.

In the digital age, reading has gone from turning pages to tapping through entire libraries on a screen. Technology is making reading not just easier, but more enjoyable.

The overall reading rate among China’s adult citizens reached 82.3 percent in 2025. On average, each adult read 8.39 printed and e-books combined that year.

On February 1, 2026, the Central Government’s regulations on public reading promotion officially took effect, marking the transition of China’s national reading drive from policy guidance to legally binding mandate. The fourth week of April each year has now been designated as National Reading Week. From April 20 to 26, 2026, China celebrates its first National Reading Week, which coincides with the 31st World Book Day on April 23. Across the country, reading events are in full swing.

Today, knowledge is advancing at a much faster pace, while people are taking on increasingly specialized roles in society. New technologies and industries, from AI to the metaverse, are evolving at great speeds.

Together, these factors have not only opened up a broad stage for young people to showcase their talent, but also placed unprecedented demands on their knowledge base and innovative capacity. Only through sustained reading and learning can they keep pace with the times and ride the wave of change.

By reading and learning, people can enrich their minds, strengthen their character and broaden their horizons, which will help them keep up in a rapidly changing world.

In reading, we cultivate wisdom. In learning, we sharpen our abilities. To carve out a successful path in life–that should be the shared pursuit of all those seeking to better themselves through reading and learning.

Comments to taoxing@cicgamericas.com

Facebook: https://www.facebook.com/reel/1150015863917319/
X: https://x.com/BeijingReview/status/2047115235572760982
TikTok: https://www.tiktok.com/@cachinachic/video/7631773127730613535?is_from_webapp=1&sender_device=pc&web_id=7227134149436605995
Website: https://www.bjreview.com/Multimedia/Video/Wisdom_Without_Borders/202604/t20260422_800435798.html

View original content to download multimedia:https://www.prnewswire.com/news-releases/beijing-review-wisdom-without-borders-people-are-born-with-different-talents-but-knowledge-grows-only-through-learning-302789944.html

SOURCE Beijing Review

Continue Reading

Technology

BDx Data Centers Secures Indonesia’s Largest Data Center Power Commitment at 1.2 GW, Strengthening Strategic Partnership with PLN Across National AI Infrastructure Platform

Published

39 minutes ago

on

June 3, 2026

By

Landmark 788 MVA allocation for CGK4 Jatiluhur, major capacity energization at CGK3A South Jakarta, and strategic grid expansion at CGK5 Suryacipta position BDx Indonesia as the nation’s largest operator-neutral AI and digital infrastructure platform

SINGAPORE and JAKARTA, Indonesia, June 3, 2026 /PRNewswire/ — BDx Data Centers (BDx) announced a series of transformative power milestones achieved in a strategic partnership with PT Perusahaan Listrik Negara (Persero) (PLN), significantly expanding Indonesia’s AI and hyperscale infrastructure capacity.

These milestones include:

Securing 788 MVA of contracted grid power for BDx’s flagship CGK4 AI Campus in Jatiluhur, West JavaSuccessfully energizing CGK3A in Cilandak, South Jakarta, with a substantial power capacity expansion to ~60 MVAAdvancing high-voltage grid infrastructure at CGK5 in Suryacipta, West Java, with up to 385 MVA of secured power capacity.

Together, these developments bring BDx Indonesia’s total secured power portfolio to 1.2 GW – representing the single largest power commitment secured by any data center operator in Indonesia. This milestone reinforces BDx’s leadership in building Indonesia’s sovereign AI, cloud, and digital economy infrastructure, while deepening its long-term strategic relationship with PLN.

Agus Hartono Wijaya, CEO of BDx Indonesia said “Reliable and scalable power is foundational to Indonesia’s AI and digital infrastructure development. PLN’s professionalism and execution have been critical in enabling the expansion of our capacity across Jakarta and West Java. This collaboration supports the build‑out of resilient, AI‑ready infrastructure that can meet long‑term demand from enterprise, hyperscale, and sovereign workloads.”

Adi Priyanto, Director Retail & Commerce of PLN said “PLN remains committed to supporting strategic digital industries through reliable and scalable power infrastructure. Our collaboration with BDx reflects PLN’s role in enabling Indonesia’s AI and digital economy to grow in a resilient and sustainable manner.”

“Indonesia’s accelerating demand for AI and digital services requires close coordination between infrastructure providers and the national power ecosystem,” said Martindar Jalu Respati, Senior Manager, Commercial & Customer Management, PLN West Java Distribution Main Unit. “PLN is proud to support the development of large-scale, high-reliability digital infrastructure that strengthens Indonesia’s competitiveness as a regional technology and AI hub.”

BDx’s Indonesia portfolio represents the most advanced AI infrastructure ecosystem in Southeast Asia. CGK4, Indonesia’s first NVIDIA DGX-Ready-certified campus, delivering up to 650 MW of renewable-aligned capacity — already supporting H100-class GPU deployments for AI training and sovereign cloud workloads. CGK3 brings liquid-cooled, high-density compute to Jakarta, purpose-built for next-generation AI platforms including NVIDIA GB200. CGK5, at 300 MW, extends BDx’s hyperscale footprint and, together with CGK4, CK5, anchors Indonesia’s sovereign AI digital infrastructure.

View original content:https://www.prnewswire.com/apac/news-releases/bdx-data-centers-secures-indonesias-largest-data-center-power-commitment-at-1-2-gw-strengthening-strategic-partnership-with-pln-across-national-ai-infrastructure-platform-302789946.html

SOURCE BDx Data Centers (BDx)

Continue Reading

Trending